These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 25329929

  • 1. Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a nation-wide cohort.
    Alroughani RA, Akhtar S, Ahmed SF, Al-Hashel JY.
    Int J Neurosci; 2015; 125(11):831-7. PubMed ID: 25329929
    [Abstract] [Full Text] [Related]

  • 2. Predictive value of clinical characteristics for 'benign' multiple sclerosis.
    Ramsaransing GS, De Keyser J.
    Eur J Neurol; 2007 Aug; 14(8):885-9. PubMed ID: 17662009
    [Abstract] [Full Text] [Related]

  • 3. Secondary progressive multiple sclerosis - clinical course and potential predictive factors.
    Pokryszko-Dragan A, Gruszka E, Bilińska M, Dubik-Jezierzańska M.
    Neurol Neurochir Pol; 2008 Aug; 42(1):6-11. PubMed ID: 18365957
    [Abstract] [Full Text] [Related]

  • 4. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C, Vukusic S.
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [Abstract] [Full Text] [Related]

  • 5. The clinical course of multiple sclerosis patients in Hong Kong.
    Lau KK, Wong WW, Sheng B, Yu IT, Fung BH, Li HL, Ma KF, Wong LK, Li PC.
    J Neurol Sci; 2008 May 15; 268(1-2):78-82. PubMed ID: 18068191
    [Abstract] [Full Text] [Related]

  • 6. Longitudinal follow-up of "benign" multiple sclerosis at 20 years.
    Sayao AL, Devonshire V, Tremlett H.
    Neurology; 2007 Feb 13; 68(7):496-500. PubMed ID: 17296915
    [Abstract] [Full Text] [Related]

  • 7. Predicting the severity of relapsing-remitting MS: the contribution of cross-sectional and short-term follow-up MRI data.
    Enzinger C, Fuchs S, Pichler A, Wallner-Blazek M, Khalil M, Langkammer C, Ropele S, Fazekas F.
    Mult Scler; 2011 Jun 13; 17(6):695-701. PubMed ID: 21228028
    [Abstract] [Full Text] [Related]

  • 8. Predictors of relapse rate in MS clinical trials.
    Held U, Heigenhauser L, Shang C, Kappos L, Polman C, Sylvia Lawry Centre for MS Research.
    Neurology; 2005 Dec 13; 65(11):1769-73. PubMed ID: 16344520
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical characteristics of multiple sclerosis in Kuwait: data from the new MS registry of Amiri Hospital.
    Alroughani R, Ashkanani A, Lamdhade S.
    Int J Neurosci; 2012 Feb 13; 122(2):82-7. PubMed ID: 21985585
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pediatric-Onset Multiple Sclerosis Disease Progression in Kuwait: A Retrospective Analysis.
    Alroughani R, Ahmed SF, Al-Hashel J.
    Pediatr Neurol; 2015 Dec 13; 53(6):508-12. PubMed ID: 26383244
    [Abstract] [Full Text] [Related]

  • 13. Natural history of secondary-progressive multiple sclerosis.
    Tremlett H, Yinshan Zhao, Devonshire V.
    Mult Scler; 2008 Apr 13; 14(3):314-24. PubMed ID: 18208898
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prevalence of cognitive impairment among Hungarian patients with relapsing-remitting multiple sclerosis and clinically isolated syndrome.
    Sandi D, Biernacki T, Szekeres D, Füvesi J, Kincses ZT, Rózsa C, Mátyás K, Kása K, Matolcsi J, Zboznovits D, Burány Z, Langane É, Vécsei L, Bencsik K.
    Mult Scler Relat Disord; 2017 Oct 13; 17():57-62. PubMed ID: 29055476
    [Abstract] [Full Text] [Related]

  • 16. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
    Brown MG, Kirby S, Skedgel C, Fisk JD, Murray TJ, Bhan V, Sketris IS.
    Neurology; 2007 Oct 09; 69(15):1498-507. PubMed ID: 17699802
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.